Ameriprise Financial Inc Bristol Myers Squibb CO Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ameriprise Financial Inc holds 19,763,674 shares of BMY stock, worth $812 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

19,763,674

Previous 27,744,111 28.76%

Holding current value

$812 Million

Previous $1.42 Billion 24.71%

% of portfolio

0.3%

Previous 0.43%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $383 Million - $434 Million	-7,980,437 Reduced 28.76%	19,763,674 $1.07 Billion
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $96.1 Million - $115 Million	1,982,050 Added 7.69%	27,744,111 $1.42 Billion
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $56.5 Million - $63.2 Million	-976,093 Reduced 3.65%	25,762,061 $1.5 Billion
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $41.7 Million - $46.3 Million	653,888 Added 2.51%	26,738,154 $1.71 Billion
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $160 Million - $182 Million	2,439,814 Added 10.32%	26,084,266 $1.81 Billion

Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $68.3 Million - $80.8 Million	-996,976 Reduced 4.05%	23,644,452 $1.7 Billion
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $56,745 - $33.5 Million	-436,501 Reduced 1.74%	24,641,428 $1.76 Billion
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $127 Million - $140 Million	-1,750,042 Reduced 6.52%	25,077,929 $1.93 Billion
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $71 Million - $85.1 Million	-1,154,799 Reduced 4.13%	26,827,971 $1.95 Billion
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $27.3 Million - $31.8 Million	-508,261 Reduced 1.78%	27,982,770 $1.73 Billion
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $102 Million - $120 Million	-1,724,907 Reduced 5.71%	28,491,031 $1.69 Billion
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $2.25 Million - $2.45 Million	-36,343 Reduced 0.12%	30,215,938 $2.02 Billion
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $88.9 Million - $100 Million	1,498,152 Added 5.21%	30,252,281 $1.91 Billion
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $37 Million - $41.9 Million	-640,901 Reduced 2.18%	28,754,129 $1.78 Billion
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $122 Million - $135 Million	-2,128,869 Reduced 6.75%	29,395,030 $1.77 Billion
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $74.8 Million - $87.4 Million	1,363,804 Added 4.52%	31,523,899 $1.85 Billion
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $139 Million - $203 Million	-3,004,927 Reduced 9.06%	30,160,095 $1.68 Billion
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $94.2 Million - $123 Million	1,914,708 Added 6.13%	33,165,022 $2.13 Billion
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $198 Million - $234 Million	4,624,215 Added 17.37%	31,250,314 $1.59 Billion
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $73.4 Million - $81.2 Million	-1,645,847 Reduced 5.82%	26,626,099 $1.21 Billion
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $65.2 Million - $77.7 Million	1,444,285 Added 5.38%	28,271,946 $1.35 Billion
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $138 Million - $179 Million	2,827,484 Added 11.78%	26,827,661 $1.39 Billion
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $4.23 Million - $4.77 Million	-76,598 Reduced 0.32%	24,000,177 $1.56 Billion
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $420 Million - $523 Million	8,303,421 Added 52.64%	24,076,775 $1.33 Billion
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $183 Million - $211 Million	3,061,221 Added 24.08%	15,773,354 $998 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $115 Million - $125 Million	-1,918,062 Reduced 13.11%	12,712,133 $780 Million
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $808 Million - $933 Million	14,630,195	14,630,195 $933 Million

Others Institutions Holding BMY

# of Institutions

2,552

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Bristol Myers Squibb CO Transaction History